ES2102830T3 - Diarilalquil piperidinas utiles como agentes para tumores con resistencia multifarmaco. - Google Patents

Diarilalquil piperidinas utiles como agentes para tumores con resistencia multifarmaco.

Info

Publication number
ES2102830T3
ES2102830T3 ES94906446T ES94906446T ES2102830T3 ES 2102830 T3 ES2102830 T3 ES 2102830T3 ES 94906446 T ES94906446 T ES 94906446T ES 94906446 T ES94906446 T ES 94906446T ES 2102830 T3 ES2102830 T3 ES 2102830T3
Authority
ES
Spain
Prior art keywords
tumors
agents
drug resistance
alkyl piperidines
diaryl alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94906446T
Other languages
English (en)
Inventor
Sai P Sunkara
Jules Freedman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2102830T3 publication Critical patent/ES2102830T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/16—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

PIPERIDINAS DIARIALQUILO DE LA FORMULA (1) SE OPONEN A LA RESISTENCIA A LA DROGA EN TUMORES RESISTENTES A MULTIDROGAS. ESTOS COMPUESTOS APARENTEMENTE FUNCIONAN MEDIANTE LA INHIBICION DE UNA BOMBA DE UNA P-GLICOPROTEINA QUE SE ACTIVA EN EL ULTIMO ESTADO DE DESARROLLO DEL TUMOR Y QUE ESTA INHERENTEMENTE PRESENTE EN TUMORES DE CIERTOS ORIGENES.
ES94906446T 1993-01-21 1993-12-17 Diarilalquil piperidinas utiles como agentes para tumores con resistencia multifarmaco. Expired - Lifetime ES2102830T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US656993A 1993-01-21 1993-01-21

Publications (1)

Publication Number Publication Date
ES2102830T3 true ES2102830T3 (es) 1997-08-01

Family

ID=21721516

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94906446T Expired - Lifetime ES2102830T3 (es) 1993-01-21 1993-12-17 Diarilalquil piperidinas utiles como agentes para tumores con resistencia multifarmaco.

Country Status (20)

Country Link
US (1) US5648365A (es)
EP (1) EP0680470B1 (es)
JP (1) JP3398748B2 (es)
KR (1) KR100377280B1 (es)
AT (1) ATE150748T1 (es)
AU (1) AU679723B2 (es)
CA (1) CA2152794C (es)
DE (1) DE69309310T2 (es)
DK (1) DK0680470T3 (es)
ES (1) ES2102830T3 (es)
FI (1) FI112474B (es)
GR (1) GR3023188T3 (es)
HU (1) HUT72078A (es)
IL (1) IL108369A (es)
MX (1) MX9400563A (es)
NO (1) NO305166B1 (es)
NZ (1) NZ261414A (es)
TW (1) TW243445B (es)
WO (1) WO1994017040A1 (es)
ZA (1) ZA94317B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ249040A (en) * 1992-02-06 1997-06-24 Merrell Dow Pharma Triphenyl azacycloalkane derivatives; treatment of drug resistance
WO2001007034A1 (en) * 1999-07-23 2001-02-01 Colorado State University Research Foundation Multidrug resistance pump inhibitors and uses thereof
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
JP2005508990A (ja) * 2001-11-07 2005-04-07 ファルマシア・コーポレーション 真核細胞におけるポリアミドの取込みおよび核蓄積を促進する方法
KR100656490B1 (ko) 2001-11-26 2006-12-12 삼성에스디아이 주식회사 풀칼라 유기전계 발광표시소자 및 그의 제조방법
US8153184B2 (en) * 2001-11-26 2012-04-10 Samsung Mobile Display Co., Ltd. Organic EL display device and method of manufacturing the same
WO2014124222A1 (en) 2013-02-08 2014-08-14 General Mills, Inc. Reduced sodium food products
CN110372571B (zh) * 2018-04-12 2022-11-15 中国科学院大连化学物理研究所 一种2-(2,2-二芳基乙基)-环胺衍生物或盐及合成和应用与组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1049377B (de) * 1952-04-03 1959-01-29 Abbott Laboratories, North Chicago, 111. (V. St. A.) Verfahren zur Herstellung von substituierten Vinylpiperidinen
US2898339A (en) * 1957-07-29 1959-08-04 Wm S Merrell Co N-substituted benzhydrol, benzhydryl, and benzhydrylidene piperidine
US3956296A (en) * 1974-12-11 1976-05-11 A. H. Robins Company, Incorporated 1-Substituted-4-benzylpiperidines
US4035372A (en) * 1976-08-13 1977-07-12 G. D. Searle & Co. 4-{[4-(Diphenylmethyl)-1-piperidinyl]methyl}benzenamines
EP0235463A3 (en) * 1985-12-20 1990-01-17 A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) N-substituted-arylalkyl and arylalkylene piperidines as cardiovascular antihistaminic and antisecretory agents
US4851423A (en) * 1986-12-10 1989-07-25 Schering Corporation Pharmaceutically active compounds
US4990511A (en) * 1988-08-03 1991-02-05 Takeda Chemical Industries, Ltd. Amide compounds, their production and use
NZ234110A (en) * 1989-06-19 1993-01-27 Wellcome Found Dibenzoazepine, -oxepine and -cycloheptane substituted alkylidene amines; pharmaceutical compositions containing such compounds or various other aryl substituted amines
GB9000305D0 (en) * 1990-01-06 1990-03-07 Pfizer Ltd Anticholinergic agents
EP0467435A3 (en) * 1990-07-19 1992-04-01 Akzo N.V. Benzhydryl derivatives having calmodulin inhibitor properties
DE69128820T2 (de) * 1990-08-14 1998-06-10 Hoechst Marion Roussel Inc Neue 19-Nor Steroide, die eine Amid tragende Gruppe in der 11-Beta-Stelle haben, ihre Herstellung, ihre Verwendung als Medikamente und pharmazeutische Präparate davon
NZ249040A (en) * 1992-02-06 1997-06-24 Merrell Dow Pharma Triphenyl azacycloalkane derivatives; treatment of drug resistance

Also Published As

Publication number Publication date
US5648365A (en) 1997-07-15
NO952885L (no) 1995-09-20
AU6014894A (en) 1994-08-15
NO952885D0 (no) 1995-07-20
IL108369A0 (en) 1994-04-12
IL108369A (en) 1999-08-17
AU679723B2 (en) 1997-07-10
EP0680470A1 (en) 1995-11-08
DE69309310T2 (de) 1997-11-06
FI112474B (fi) 2003-12-15
ATE150748T1 (de) 1997-04-15
FI953506A (fi) 1995-07-20
MX9400563A (es) 1994-07-29
JPH08505870A (ja) 1996-06-25
HU9502195D0 (en) 1995-09-28
NZ261414A (en) 1997-06-24
EP0680470B1 (en) 1997-03-26
CA2152794A1 (en) 1994-08-04
DK0680470T3 (es) 1997-04-28
JP3398748B2 (ja) 2003-04-21
WO1994017040A1 (en) 1994-08-04
CA2152794C (en) 1999-04-06
DE69309310D1 (de) 1997-04-30
KR100377280B1 (ko) 2003-07-18
GR3023188T3 (en) 1997-07-30
HUT72078A (en) 1996-03-28
NO305166B1 (no) 1999-04-12
KR960700230A (ko) 1996-01-19
FI953506A0 (fi) 1995-07-20
TW243445B (es) 1995-03-21
ZA94317B (en) 1994-08-18

Similar Documents

Publication Publication Date Title
SV1999000048A (es) Uso de dihidropiriminas como medicamento y nuevas sustancias ref. lea 32 791-sv
ES2174989T3 (es) Pirido(3,2-e)pirazinonas con antiasmatica y procedimiento para su preparacion.
AR018732A1 (es) Iminoazucares alquilados para prevenir, reducir o revertir la resistencia a la multidroga en el tratamiento quimioterapeutico y composicionfarmaceutica que los contiene.
ES2179945T3 (es) Compuestos de tetralina con actividad de resistencia a multiples farmacos.
ES2102830T3 (es) Diarilalquil piperidinas utiles como agentes para tumores con resistencia multifarmaco.
PA8432901A1 (es) Compuestos de piridilpirrol
ES2150663T3 (es) Tratamiento de la incontinencia urinaria utilizando (s)-oxibutinina y (s)-desetiloxibutinina.
SV2002000232A (es) Derivados nuevos de benzoimidazole utiles como agentes antiproliferativos ref. pc 10608abcz/bb
KR960705810A (ko) 퀴나졸린 유도체(quinazoline derivatives)
ES2152310T3 (es) Derivados de 1-amino-3-fenoxipropano como moduladores de la resistencia a multiples a farmacos.
MX9303466A (es) Derivados de bifenilo, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
AR012878A1 (es) Un compuesto derivado de 5'-desoxicitidina, su uso, un proceso para fabricarlo, composiciones farmaceuticas que lo comprende, y un kit que comprende dicha composicion.
ATE106749T1 (de) Tumor- oder krebszelltötende therapie und demgemäss verwendbare wirkstoffe.
BR0208405A (pt) Compostos de diidropirimina substituìdos com ciano e seu uso para tratar doenças
AR018162A1 (es) Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica
ES2179332T3 (es) Repelentes de artropodos.
CO5050328A1 (es) Sistema solvente para la mejor penetracion de compuestos farmaceuticos
ES2166128T3 (es) Mezcla fungicida.
ES2094525T3 (es) Anulacion de resistencia a multiples farmacos por tetraariletilenos.
AR003137A1 (es) Una composicion farmaceutica para tratar la leucemia
ES2043863T3 (es) Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina.
GT199600101A (es) Derivados de octahidro-pirrolo (1,2,-a)-pirazina 2,7-sustituidos
MX9401080A (es) Compuestos heteroaromaticos.
ES2070002T3 (es) Composiciones terapeuticas a base de derivados de 1,2-ditiol-3-tiona.
ES2061811T3 (es) Uso de compuestos de gamma-oxibutenolido conjugados para tratar ulcera.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 680470

Country of ref document: ES